カテゴリー： Market Monitor Global, 世界, 医療/バイオ

処方プロトンポンプ阻害剤の世界市場見通し2023年-2029年

◆英語タイトル：Prescription Proton Pump Inhibitor Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8599 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：73 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Prescription Proton Pump Inhibitor Market 調査レポートは次の情報を含め、グローバルにおけるの処方プロトンポンプ阻害剤市場規模と予測を収録しています。・世界の処方プロトンポンプ阻害剤市場：売上、2018年-2023年、2024年-2029年
・世界の処方プロトンポンプ阻害剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の処方プロトンポンプ阻害剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ランソプラゾール」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

処方プロトンポンプ阻害剤のグローバル主要企業は、AstraZeneca、 Cadila Pharmaceuticals、 Eisai、 Eli Lilly、 Janssen、 Pfizer、 Santarus、 Wyethなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、処方プロトンポンプ阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の処方プロトンポンプ阻害剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の処方プロトンポンプ阻害剤市場：タイプ別市場シェア、2022年
・ランソプラゾール、パントプラゾール、ラベプラゾール、その他

世界の処方プロトンポンプ阻害剤市場：用途別、2018年-2023年、2024年-2029年
世界の処方プロトンポンプ阻害剤市場：用途別市場シェア、2022年
・病院、研究所、その他

世界の処方プロトンポンプ阻害剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の処方プロトンポンプ阻害剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における処方プロトンポンプ阻害剤のグローバル売上、2018年-2023年
・主要企業における処方プロトンポンプ阻害剤のグローバル売上シェア、2022年
・主要企業における処方プロトンポンプ阻害剤のグローバル販売量、2018年-2023年
・主要企業における処方プロトンポンプ阻害剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AstraZeneca、 Cadila Pharmaceuticals、 Eisai、 Eli Lilly、 Janssen、 Pfizer、 Santarus、 Wyeth

*************************************************************

・調査・分析レポートの概要
処方プロトンポンプ阻害剤市場の定義
市場セグメント
世界の処方プロトンポンプ阻害剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の処方プロトンポンプ阻害剤市場規模
世界の処方プロトンポンプ阻害剤市場規模：2022年 VS 2029年
世界の処方プロトンポンプ阻害剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの処方プロトンポンプ阻害剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の処方プロトンポンプ阻害剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ランソプラゾール、パントプラゾール、ラベプラゾール、その他
処方プロトンポンプ阻害剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、研究所、その他
処方プロトンポンプ阻害剤の用途別グローバル売上・予測

・地域別市場分析
地域別処方プロトンポンプ阻害剤市場規模 2022年と2029年
地域別処方プロトンポンプ阻害剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AstraZeneca、 Cadila Pharmaceuticals、 Eisai、 Eli Lilly、 Janssen、 Pfizer、 Santarus、 Wyeth
...

Proton-pump inhibitors (PPIs) are members of a class of medications whose main action is a profound and prolonged reduction of stomach acid production.
This report aims to provide a comprehensive presentation of the global market for Prescription Proton Pump Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Proton Pump Inhibitor. This report contains market size and forecasts of Prescription Proton Pump Inhibitor in global, including the following market information:
Global Prescription Proton Pump Inhibitor Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prescription Proton Pump Inhibitor Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Prescription Proton Pump Inhibitor companies in 2022 (%)
The global Prescription Proton Pump Inhibitor market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Lansoprazole Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prescription Proton Pump Inhibitor include AstraZeneca, Cadila Pharmaceuticals, Eisai, Eli Lilly, Janssen, Pfizer, Santarus and Wyeth, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Proton Pump Inhibitor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Proton Pump Inhibitor Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Proton Pump Inhibitor Market Segment Percentages, by Type, 2022 (%)
Lansoprazole
Pantoprazole
Rabeprazole
Others
Global Prescription Proton Pump Inhibitor Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Proton Pump Inhibitor Market Segment Percentages, by Application, 2022 (%)
Hospital
Laboratory
Others
Global Prescription Proton Pump Inhibitor Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Proton Pump Inhibitor Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Proton Pump Inhibitor revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prescription Proton Pump Inhibitor revenues share in global market, 2022 (%)
Key companies Prescription Proton Pump Inhibitor sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prescription Proton Pump Inhibitor sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Cadila Pharmaceuticals
Eisai
Eli Lilly
Janssen
Pfizer
Santarus
Wyeth
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prescription Proton Pump Inhibitor, market overview.
Chapter 2: Global Prescription Proton Pump Inhibitor market size in revenue and volume.
Chapter 3: Detailed analysis of Prescription Proton Pump Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription Proton Pump Inhibitor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prescription Proton Pump Inhibitor capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Prescription Proton Pump Inhibitor Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prescription Proton Pump Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prescription Proton Pump Inhibitor Overall Market Size
2.1 Global Prescription Proton Pump Inhibitor Market Size: 2022 VS 2029
2.2 Global Prescription Proton Pump Inhibitor Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Prescription Proton Pump Inhibitor Sales: 2018-2029
3 Company Landscape
3.1 Top Prescription Proton Pump Inhibitor Players in Global Market
3.2 Top Global Prescription Proton Pump Inhibitor Companies Ranked by Revenue
3.3 Global Prescription Proton Pump Inhibitor Revenue by Companies
3.4 Global Prescription Proton Pump Inhibitor Sales by Companies
3.5 Global Prescription Proton Pump Inhibitor Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prescription Proton Pump Inhibitor Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prescription Proton Pump Inhibitor Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prescription Proton Pump Inhibitor Players in Global Market
3.8.1 List of Global Tier 1 Prescription Proton Pump Inhibitor Companies
3.8.2 List of Global Tier 2 and Tier 3 Prescription Proton Pump Inhibitor Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Prescription Proton Pump Inhibitor Market Size Markets, 2022 & 2029
4.1.2 Lansoprazole
4.1.3 Pantoprazole
4.1.4 Rabeprazole
4.1.5 Others
4.2 By Type – Global Prescription Proton Pump Inhibitor Revenue & Forecasts
4.2.1 By Type – Global Prescription Proton Pump Inhibitor Revenue, 2018-2023
4.2.2 By Type – Global Prescription Proton Pump Inhibitor Revenue, 2024-2029
4.2.3 By Type – Global Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
4.3 By Type – Global Prescription Proton Pump Inhibitor Sales & Forecasts
4.3.1 By Type – Global Prescription Proton Pump Inhibitor Sales, 2018-2023
4.3.2 By Type – Global Prescription Proton Pump Inhibitor Sales, 2024-2029
4.3.3 By Type – Global Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
4.4 By Type – Global Prescription Proton Pump Inhibitor Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Prescription Proton Pump Inhibitor Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Laboratory
5.1.4 Others
5.2 By Application – Global Prescription Proton Pump Inhibitor Revenue & Forecasts
5.2.1 By Application – Global Prescription Proton Pump Inhibitor Revenue, 2018-2023
5.2.2 By Application – Global Prescription Proton Pump Inhibitor Revenue, 2024-2029
5.2.3 By Application – Global Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
5.3 By Application – Global Prescription Proton Pump Inhibitor Sales & Forecasts
5.3.1 By Application – Global Prescription Proton Pump Inhibitor Sales, 2018-2023
5.3.2 By Application – Global Prescription Proton Pump Inhibitor Sales, 2024-2029
5.3.3 By Application – Global Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
5.4 By Application – Global Prescription Proton Pump Inhibitor Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Prescription Proton Pump Inhibitor Market Size, 2022 & 2029
6.2 By Region – Global Prescription Proton Pump Inhibitor Revenue & Forecasts
6.2.1 By Region – Global Prescription Proton Pump Inhibitor Revenue, 2018-2023
6.2.2 By Region – Global Prescription Proton Pump Inhibitor Revenue, 2024-2029
6.2.3 By Region – Global Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
6.3 By Region – Global Prescription Proton Pump Inhibitor Sales & Forecasts
6.3.1 By Region – Global Prescription Proton Pump Inhibitor Sales, 2018-2023
6.3.2 By Region – Global Prescription Proton Pump Inhibitor Sales, 2024-2029
6.3.3 By Region – Global Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Prescription Proton Pump Inhibitor Revenue, 2018-2029
6.4.2 By Country – North America Prescription Proton Pump Inhibitor Sales, 2018-2029
6.4.3 US Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.4.4 Canada Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.4.5 Mexico Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Prescription Proton Pump Inhibitor Revenue, 2018-2029
6.5.2 By Country – Europe Prescription Proton Pump Inhibitor Sales, 2018-2029
6.5.3 Germany Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.5.4 France Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.5.5 U.K. Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.5.6 Italy Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.5.7 Russia Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.5.8 Nordic Countries Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.5.9 Benelux Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Prescription Proton Pump Inhibitor Revenue, 2018-2029
6.6.2 By Region – Asia Prescription Proton Pump Inhibitor Sales, 2018-2029
6.6.3 China Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.6.4 Japan Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.6.5 South Korea Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.6.6 Southeast Asia Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.6.7 India Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Prescription Proton Pump Inhibitor Revenue, 2018-2029
6.7.2 By Country – South America Prescription Proton Pump Inhibitor Sales, 2018-2029
6.7.3 Brazil Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.7.4 Argentina Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Prescription Proton Pump Inhibitor Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Prescription Proton Pump Inhibitor Sales, 2018-2029
6.8.3 Turkey Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.8.4 Israel Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.8.5 Saudi Arabia Prescription Proton Pump Inhibitor Market Size, 2018-2029
6.8.6 UAE Prescription Proton Pump Inhibitor Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Prescription Proton Pump Inhibitor Major Product Offerings
7.1.4 AstraZeneca Prescription Proton Pump Inhibitor Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Company Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Major Product Offerings
7.2.4 Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Sales and Revenue in Global (2018-2023)
7.2.5 Cadila Pharmaceuticals Key News & Latest Developments
7.3 Eisai
7.3.1 Eisai Company Summary
7.3.2 Eisai Business Overview
7.3.3 Eisai Prescription Proton Pump Inhibitor Major Product Offerings
7.3.4 Eisai Prescription Proton Pump Inhibitor Sales and Revenue in Global (2018-2023)
7.3.5 Eisai Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Prescription Proton Pump Inhibitor Major Product Offerings
7.4.4 Eli Lilly Prescription Proton Pump Inhibitor Sales and Revenue in Global (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Janssen
7.5.1 Janssen Company Summary
7.5.2 Janssen Business Overview
7.5.3 Janssen Prescription Proton Pump Inhibitor Major Product Offerings
7.5.4 Janssen Prescription Proton Pump Inhibitor Sales and Revenue in Global (2018-2023)
7.5.5 Janssen Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Prescription Proton Pump Inhibitor Major Product Offerings
7.6.4 Pfizer Prescription Proton Pump Inhibitor Sales and Revenue in Global (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Santarus
7.7.1 Santarus Company Summary
7.7.2 Santarus Business Overview
7.7.3 Santarus Prescription Proton Pump Inhibitor Major Product Offerings
7.7.4 Santarus Prescription Proton Pump Inhibitor Sales and Revenue in Global (2018-2023)
7.7.5 Santarus Key News & Latest Developments
7.8 Wyeth
7.8.1 Wyeth Company Summary
7.8.2 Wyeth Business Overview
7.8.3 Wyeth Prescription Proton Pump Inhibitor Major Product Offerings
7.8.4 Wyeth Prescription Proton Pump Inhibitor Sales and Revenue in Global (2018-2023)
7.8.5 Wyeth Key News & Latest Developments
8 Global Prescription Proton Pump Inhibitor Production Capacity, Analysis
8.1 Global Prescription Proton Pump Inhibitor Production Capacity, 2018-2029
8.2 Prescription Proton Pump Inhibitor Production Capacity of Key Manufacturers in Global Market
8.3 Global Prescription Proton Pump Inhibitor Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prescription Proton Pump Inhibitor Supply Chain Analysis
10.1 Prescription Proton Pump Inhibitor Industry Value Chain
10.2 Prescription Proton Pump Inhibitor Upstream Market
10.3 Prescription Proton Pump Inhibitor Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prescription Proton Pump Inhibitor Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Prescription Proton Pump Inhibitor in Global Market
Table 2. Top Prescription Proton Pump Inhibitor Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prescription Proton Pump Inhibitor Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Prescription Proton Pump Inhibitor Revenue Share by Companies, 2018-2023
Table 5. Global Prescription Proton Pump Inhibitor Sales by Companies, (K Units), 2018-2023
Table 6. Global Prescription Proton Pump Inhibitor Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Prescription Proton Pump Inhibitor Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Prescription Proton Pump Inhibitor Product Type
Table 9. List of Global Tier 1 Prescription Proton Pump Inhibitor Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prescription Proton Pump Inhibitor Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Prescription Proton Pump Inhibitor Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Prescription Proton Pump Inhibitor Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Prescription Proton Pump Inhibitor Sales (K Units), 2018-2023
Table 15. By Type - Global Prescription Proton Pump Inhibitor Sales (K Units), 2024-2029
Table 16. By Application – Global Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Prescription Proton Pump Inhibitor Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Prescription Proton Pump Inhibitor Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Prescription Proton Pump Inhibitor Sales (K Units), 2018-2023
Table 20. By Application - Global Prescription Proton Pump Inhibitor Sales (K Units), 2024-2029
Table 21. By Region – Global Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Prescription Proton Pump Inhibitor Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Prescription Proton Pump Inhibitor Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Prescription Proton Pump Inhibitor Sales (K Units), 2018-2023
Table 25. By Region - Global Prescription Proton Pump Inhibitor Sales (K Units), 2024-2029
Table 26. By Country - North America Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Prescription Proton Pump Inhibitor Sales, (K Units), 2018-2023
Table 29. By Country - North America Prescription Proton Pump Inhibitor Sales, (K Units), 2024-2029
Table 30. By Country - Europe Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Prescription Proton Pump Inhibitor Sales, (K Units), 2018-2023
Table 33. By Country - Europe Prescription Proton Pump Inhibitor Sales, (K Units), 2024-2029
Table 34. By Region - Asia Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Prescription Proton Pump Inhibitor Sales, (K Units), 2018-2023
Table 37. By Region - Asia Prescription Proton Pump Inhibitor Sales, (K Units), 2024-2029
Table 38. By Country - South America Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Prescription Proton Pump Inhibitor Sales, (K Units), 2018-2023
Table 41. By Country - South America Prescription Proton Pump Inhibitor Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Prescription Proton Pump Inhibitor Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Prescription Proton Pump Inhibitor Sales, (K Units), 2024-2029
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Prescription Proton Pump Inhibitor Product Offerings
Table 48. AstraZeneca Prescription Proton Pump Inhibitor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Cadila Pharmaceuticals Company Summary
Table 51. Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Product Offerings
Table 52. Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Cadila Pharmaceuticals Key News & Latest Developments
Table 54. Eisai Company Summary
Table 55. Eisai Prescription Proton Pump Inhibitor Product Offerings
Table 56. Eisai Prescription Proton Pump Inhibitor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Eisai Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Prescription Proton Pump Inhibitor Product Offerings
Table 60. Eli Lilly Prescription Proton Pump Inhibitor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Eli Lilly Key News & Latest Developments
Table 62. Janssen Company Summary
Table 63. Janssen Prescription Proton Pump Inhibitor Product Offerings
Table 64. Janssen Prescription Proton Pump Inhibitor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Janssen Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Prescription Proton Pump Inhibitor Product Offerings
Table 68. Pfizer Prescription Proton Pump Inhibitor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Pfizer Key News & Latest Developments
Table 70. Santarus Company Summary
Table 71. Santarus Prescription Proton Pump Inhibitor Product Offerings
Table 72. Santarus Prescription Proton Pump Inhibitor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Santarus Key News & Latest Developments
Table 74. Wyeth Company Summary
Table 75. Wyeth Prescription Proton Pump Inhibitor Product Offerings
Table 76. Wyeth Prescription Proton Pump Inhibitor Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Wyeth Key News & Latest Developments
Table 78. Prescription Proton Pump Inhibitor Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Prescription Proton Pump Inhibitor Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Prescription Proton Pump Inhibitor Production by Region, 2018-2023 (K Units)
Table 81. Global Prescription Proton Pump Inhibitor Production by Region, 2024-2029 (K Units)
Table 82. Prescription Proton Pump Inhibitor Market Opportunities & Trends in Global Market
Table 83. Prescription Proton Pump Inhibitor Market Drivers in Global Market
Table 84. Prescription Proton Pump Inhibitor Market Restraints in Global Market
Table 85. Prescription Proton Pump Inhibitor Raw Materials
Table 86. Prescription Proton Pump Inhibitor Raw Materials Suppliers in Global Market
Table 87. Typical Prescription Proton Pump Inhibitor Downstream
Table 88. Prescription Proton Pump Inhibitor Downstream Clients in Global Market
Table 89. Prescription Proton Pump Inhibitor Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prescription Proton Pump Inhibitor Segment by Type in 2022
Figure 2. Prescription Proton Pump Inhibitor Segment by Application in 2022
Figure 3. Global Prescription Proton Pump Inhibitor Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prescription Proton Pump Inhibitor Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prescription Proton Pump Inhibitor Revenue, 2018-2029 (US$, Mn)
Figure 7. Prescription Proton Pump Inhibitor Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prescription Proton Pump Inhibitor Revenue in 2022
Figure 9. By Type - Global Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
Figure 11. By Type - Global Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
Figure 12. By Type - Global Prescription Proton Pump Inhibitor Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
Figure 15. By Application - Global Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
Figure 16. By Application - Global Prescription Proton Pump Inhibitor Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Prescription Proton Pump Inhibitor Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
Figure 20. By Region - Global Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
Figure 21. By Country - North America Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
Figure 22. By Country - North America Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
Figure 23. US Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
Figure 28. Germany Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 29. France Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
Figure 37. China Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 41. India Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
Figure 43. By Country - South America Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
Figure 44. Brazil Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Prescription Proton Pump Inhibitor Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Prescription Proton Pump Inhibitor Sales Market Share, 2018-2029
Figure 48. Turkey Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Prescription Proton Pump Inhibitor Revenue, (US$, Mn), 2018-2029
Figure 52. Global Prescription Proton Pump Inhibitor Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Prescription Proton Pump Inhibitor by Region, 2022 VS 2029
Figure 54. Prescription Proton Pump Inhibitor Industry Value Chain
Figure 55. Marketing Channels

※参考情報

プロトンポンプ阻害剤（PPI）は、胃酸の分泌を抑えるために広く用いられる薬剤であり、胃腸関連の病状の治療において重要な役割を果たしています。以下に、PPIの定義、特徴、種類、用途、および関連技術について詳しく説明いたします。

PPIの定義としては、胃壁細胞内のプロトンポンプと呼ばれる酵素を阻害することにより、胃酸の分泌を抑制する薬剤のことを指します。プロトンポンプは、胃の酸を生成する際に重要な役割を果たしているため、その機能を阻害することで、胃酸の分泌を効果的に減少させることができます。この作用により、胃酸過多によって引き起こされるさまざまな疾患の治療に寄与しています。

PPIの特徴としては、まずその効果の持続時間が挙げられます。PPIは服用後数時間で効果を発現し、その後も数日間にわたって胃酸の分泌を抑制することができます。このため、一日一回の服用で済むことが多く、患者にとっても非常に便利な薬剤です。また、PPIは、他の胃酸抑制剤に比べて優れた選択性を持ち、特定の刺激に対して高い効果を示すことが特長です。

PPIは、さまざまな種類が存在しています。代表的な薬剤には、オメプラゾール、ランソプラゾール、エソメプラゾール、ラベプラゾール、あららんなどがあります。これらの薬剤はそれぞれ異なる薬効や適応があり、患者の状態や症状に応じて選択されます。オメプラゾールは最も広く使用されており、初めてのPPIとして知られています。他のPPIも、作用機序や副作用のプロファイルが異なり、個々の患者に合わせた選択が求められます。

PPIの用途は多岐にわたっており、主に胃酸過多に関連する疾患の治療に用いられます。代表的な疾患には、胃食道逆流症（GERD）、消化性潰瘍、非ステロイド性抗炎症薬（NSAIDs）による胃潰瘍の予防、ヘリコバクター・ピロリ感染の治療などがあります。特にGERDに対しては、食道の下部括約筋の圧力を改善し、逆流を減少させることにより、症状の軽減が期待されます。また、潰瘍の治療においては、胃酸の分泌を抑えることによって潰瘍の治癒を促進する効果があります。

PPIは広く使用されている一方で、いくつかの注意点や副作用も存在します。長期的な使用により、腎機能障害、骨折リスクの増加、感染症のリスク（特にクロストリジウム・ディフィシル感染）などが報告されています。これらのリスクのため、医師は患者の状態を考慮しながら、使用期間を最小限に抑える方針をとることが求められます。また、低用量から開始し、必要に応じて用量を調整することも重要です。

PPIの関連技術には、投与方法や製剤技術の進展があります。最近では、腸溶性製剤や持続性製剤など、薬剤の吸収を最適化するための製剤技術が開発されています。このような技術により、PPIの効果がさらに向上し、患者の服用負担も軽減されることが期待されています。

また、PPIの使用に際しては、相互作用にも注意が必要です。特に、PPIは他の薬剤の吸収や代謝に影響を与えることがあるため、併用薬剤との関係をよく理解し、適切に使用することが求められます。例えば、PPIは特定の抗ウイルス薬や抗真菌薬、抗がん剤との相互作用が知られており、医師や薬剤師はこれらの情報を考慮しながら、治療方針を決定する必要があります。

最後に、PPIの治療においては、患者教育も重要な要素となります。患者に対し、PPIの目的や効果、副作用のリスクについて十分に説明し、理解を得ることが求められます。また、治療中に変化があれば速やかに医師に相談するよう促し、適切なフォローアップを行うことが、効果的な治療につながります。

結論として、プロトンポンプ阻害剤は胃酸過多に関連するさまざまな疾患の治療において、非常に効果的な薬剤です。その特性や作用機序、使用上の注意ことを理解し、適切に使用することが、患者のQOL（生活の質）を向上させるために不可欠です。PPIの今後の研究や技術開発にも期待が寄せられ、胃腸疾患治療における新たな展望が開かれることでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 処方プロトンポンプ阻害剤の世界市場見通し2023年-2029年(Prescription Proton Pump Inhibitor Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

処方プロトンポンプ阻害剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp